Key People‎ > ‎

John-Peter Bradford

John-Peter Bradford, Ph.D., FCMC
John-Peter is the CEO of Bradford Bachinski Limited -- and an experienced CEO, Chairman and board member of both publicly listed (NASDAQ, TSE, TSX-V) and private companies. As an consultant, he has served as an interim senior executive and provides advice to senior management and boards on corporate strategy, corporate structuring, deal making, corporate finance and a variety of management issues. He also specializes in building high functioning senior management teams and boards.

He has worked with start-ups, early stage, growth and restructuring situations. He has been a partner in three Canadian Exempt Market Dealers, and has helped raise hundreds of millions of dollars.

In the public sector, he coordinated the development of the Inuit land claim that was presented to the Trudeau government in 1976, and was the basis for the formation of Nunavut, Canada's newest territory.

John-Peter also served as principal advisor in restructuring, quality enhancement and infrastructure renewals of the House of Commons, Supreme Court of Canada, Canadian Commercial Corporation, Medical Research Council of Canada, HRDC (nationally and regionally), Immigration Refugee Board, IDRC and others.  

A passionate patient advocate and long term cancer survivor, John-Peter is founding CEO and board member of LSTN (Life-Saving Therapies Network), which is dedicated to faster development of and access to better drug therapies for use in lethal diseases like cancer. He has served on the Research Advisory Group of the Canadian Partnership Against Cancer, the Cancer Care Advisory Committee of the Ottawa Regional Cancer Foundation, the Advocacy Committee of Lung Cancer Canada and as an Advisor to the Patients Association of Canada.  His book "Journeys in Cancerland", with Lisa Newman, was published in 2012. 

John-Peter has practiced interest-based negotiation, business mediation, divorce mediator and was a psychotherapist. His eclectic interests have led him to publish in magazines, newspapers, literary periodicals and peer-reviewed scientific journals on topics ranging from business to healthcare reform to current affairs to psychopharmacology and animal behaviour.